IDH1 and central nervous system cancer: Accordingly, inhibition of IDH1 by shRNA in glioma-initiating cells leads to increased histone trimethylation on H3K4, H3K9, H3K27, enhanced susceptibility to differentiation stimuli, and reduces stem cell frequency.